S-Ventures PLC - Update on the release of audited accounts FYE 2022
Announcement provided by
S-Ventures Plc · SVEN15/03/2023 10:59
15 March 2023
S-VENTURES PLC
("S-Ventures" or the "Company")
Update on the release of consolidated audited financial statements as of 30 September 2022
S-Ventures plc (AQSE: SVEN) (OTCQB: SVTPF), the enterprise company investing in and growing exciting brands across the natural, wellness and food-tech categories, would like to provide an update regarding the delay to the publication of the consolidated audited results of S-Ventures and its subsidiaries (the "Group") for the financial year ended 30 September 2022 ("FYE 2022").
The Company is required to publish its audited results by 31 March 2023. The audit process is ongoing, certain areas have taken longer than anticipated including the appropriate accounting treatment and associated costs of previous acquisitions undertaken by the Company.
The Company will continue to work closely with the auditors to ensure that the audited results for the FYE 2022 are published as soon as possible. This is expected latest by the end of April 2023.
Following the above, the Company's listing shares will be suspended with effect from 3 April 2023. The Company will request a restoration of the listing of its listing shares upon the publication of its FYE 2022 audited results.
For further information, please contact:
|
The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer) |
+44 (0) 1932 400 224 |
|
|
|
|
AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca Evon Chan Matthew Harker |
+44 (0) 20 3005 5000 |
|
|
|
|
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler |
+44 (0) 20 3934 6630 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
